Monitor for additional insider selling in coming weeks, isolated small sales are routine, but a pattern could signal concern. The large grants suggest long-term retention incentives remain intact.
PEPG drugs
PEPG drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 4 $6.76entry
- T+1 · 9mo ago −18.57%α −17.99% · $5.51
- T+5 · 8mo ago −6.95%α −5.62% · $6.29
- T+20 · 8mo ago −74.26%α −69.84% · $1.74
- T+60 · 6mo ago −77.81%α −87.90% · $1.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
PepGen insiders executed a mix of open-market sales and non-cash award grants. CEO and CFO sold a combined $44.7K in shares, while all five C-suite executives received stock awards totaling over 379K shares. The sales represent a small fraction of market cap and are likely part of pre-arranged plans, while the grants are routine compensation.
Key Financial Metrics
Key Facts
- CEO James McArthur sold 5,144 shares for $32,047; CFO Noel Donnelly sold 2,032 shares for $12,659, total open-market sales: $44,706
- All five C-suite executives received non-cash stock awards on March 1, 2026, totaling 379,355 shares with $0 transaction value
- Total dollar value of open-market activity: $44,706, representing just 0.012% of $378M market cap
- No board members or non-executive insiders involved; all transactions tied to executive compensation and planned sales
Financial Impact
$44,706 in net insider selling, offset by $0 in non-cash grants
Risk Factors
- Perception risk if media or retail investors misinterpret routine sales as negative signal
- Future dilution from granted shares, though not immediate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-PEPG-1772831553882 |
Track record
12 reports on PEPG
5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +31.95% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $4.36 to $4.19 Now $4.19 +3.90% ▲ +3.90% +1.99% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $4.36 to $4.19 Now $4.19 +3.90% ▲ +3.90% +1.99% vs SPY
- Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $5.26 to $5.04 Now $4.19 +20.34% ▲ +4.18% +3.83% vs SPY
- Nov 10, 20266d ago 8-K Bullish 7/10 Entry $4.61 to $5.26 Now $4.19 −9.11% ▲ +14.10% +12.78% vs SPY
- Aug 6, 202614w ago 8-K Bullish 7/10 Entry $2.41 to $2.85 Now $4.19 +73.86% ▲ +18.26% +17.65% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $1.51 to $1.47 Now $4.19 +177.48% ▼ −2.65% −3.19% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $1.51 to $1.47 Now $4.19 +177.48% ▼ −2.65% −3.19% vs SPY
- May 22, 202625w ago EFFECT Bearish 7/10 Entry $1.51 to $1.53 Now $4.19 −177.48% ▼ −1.32% −0.74% vs SPY
- May 19, 202625w ago S-3 Bearish 7/10 Entry $1.38 to $1.44 Now $4.19 −203.62% ▼ −4.35% −3.31% vs SPY
- May 12, 202626w ago 8-K Neutral 5/10 Entry $1.78 to $1.78 Now $4.19 +135.39% · 0.00% +0.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers